Zemplar and Bedridden - a phase IV clinical study of FDA data

Summary:

Bedridden is reported as a side effect among people who take Zemplar (paricalcitol), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Diazepam, and have Hyperparathyroidism secondary.

The phase IV clinical study analyzes which people have Bedridden when taking Zemplar. It is created by eHealthMe based on reports of 15,456 people who have side effects when taking Zemplar from the FDA, and is updated regularly.

What is Zemplar?

Zemplar has active ingredients of paricalcitol. It is often used in kidney disease. eHealthMe is studying from 15,494 Zemplar users. Check the latest studies of Zemplar.

What is Bedridden?

Bedridden is found to be associated with 874 drugs and 1,106 conditions by eHealthMe. Check the latest studies of Bedridden.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

15,456 people reported to have side effects when taking Zemplar.
Among them, 15 people (0.1%) have Bedridden.

Among these 15 people:

How long have people been on Zemplar when they have Bedridden? *

What is the gender of people who have Bedridden when taking Zemplar? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Bedridden when taking Zemplar? *

What are other drugs people take besides Zemplar? *

What are other side effects people have besides Bedridden? *

Mobility Decreased (ability to move is reduced): 7 people, 46.67%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 40.00%
Joint Pain: 5 people, 33.33%
General Physical Health Deterioration (weak health status): 5 people, 33.33%
Muscle Spasms (muscle contraction): 4 people, 26.67%
Fatigue (feeling of tiredness): 4 people, 26.67%
Confusional State: 4 people, 26.67%
Fall: 4 people, 26.67%
Micturition Frequency Decreased (less frequency of urinate): 4 people, 26.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 20.00%

What are the existing conditions these people have? *

Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 6 people, 40.00%
Anaemia (lack of blood): 4 people, 26.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 20.00%
Chronic Renal Failure (kidney failure): 3 people, 20.00%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 2 people, 13.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.67%
Pneumonia: 1 person, 6.67%
Pain: 1 person, 6.67%
Neuropathy Peripheral (surface nerve damage): 1 person, 6.67%
Lung Disorder (lung disease): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zemplar and have Bedridden?

- Check whether Bedridden is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zemplar:

Zemplar (15,494 reports)

Bedridden treatments and more:

Bedridden (14,887 reports)

Browse all side effects of Zemplar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bedridden:

Bedridden (874 drugs)

Browse all the conditions that are associated with Bedridden:

Bedridden (1,106 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paricalcitol (the active ingredients of Zemplar) and Zemplar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.